ArticleEuropean journal of medicinal chemistry2013

Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Maria Paola Giovannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.